<?xml version="1.0" encoding="UTF-8"?>
<ref id="B131">
 <label>131.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sallard</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Lescure</surname>
    <given-names>FX</given-names>
   </name>
   <name>
    <surname>Yazdanpanah</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Mentre</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Peiffer-Smadja</surname>
    <given-names>N</given-names>
   </name>
  </person-group>. 
  <article-title>Type 1 interferons as a potential treatment against COVID-19</article-title>. 
  <source>Antiviral Res.</source> (
  <year>2020</year>) 
  <volume>178</volume>:
  <fpage>1</fpage>â€“
  <lpage>4</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2020.104791</pub-id>
  <?supplied-pmid 32275914?>
  <pub-id pub-id-type="pmid">32275914</pub-id>
 </mixed-citation>
</ref>
